Bulat Khasanov

Mr. Bulat Khasanov

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2026 in Nanomaterials
Verified
Journal Article
Open access
PDF file
ASAleksandra V. Sen'kova
Aleksandra V. Sen'kova
ISInnokenty A. Savin
Innokenty A. Savin
OKOlga Kotova
Olga Kotova
ISIlya Shpagin
Ilya Shpagin
EDElena Dmitrienko
Elena Dmitrienko
MZMarina Zenkova
Marina Zenkova
Occupational chronic obstructive pulmonary disease (O-COPD) represents a lung disorder attributable to occupational exposures that are characterized by early development of airway remodeling and pulmonary fibrosis. O-COPD is poorly recapitulated by existing preclinical models. This study aimed to perform comparative characterization of an O-COPD patient cohort exposed to industrial aerosols and to develop a relevant murine model that accurately mirrors the human pathology. In the patient cohort, it was shown that the O-COPD phenotype is associated with the chemical composition of industrial aerosols and mediated by a specific inflammatory pattern with predominant obstructive changes and increased bronchial reactivity upon exposure to metal particles, as well as irreversible fibrotic changes in the lungs upon exposure to silicon dioxide. In the murine model, silica nanoparticles (SiNPs) or magnetic nanoparticles (MNPs) were utilized. Repeated intranasal SiNP administrations have been shown to reflect one of the main features of O-COPD—progressive airway remodeling and fibrosis, observed even after elimination of SiNPs. Administration of MNPs in the same regimen did not result in fibrotic changes in the lungs, partially recapitulating the human pathology resulting from exposure to the complex composition of industrial aerosols as well as the specific properties of chemically synthesized nanoparticles. Thus, the integrative data from the human cohort and animal model provides a reflective platform to advance the investigation of O-COPD mechanisms and development of interventions for fibrotic lung pathology.

15 November 2026 in Polymers
Verified
Journal Article
Open access
PDF file
VPVictoriya Popova
Victoriya Popova
BKBulat Khasanov
Bulat Khasanov
Dingxin LiuDingxin Liu
Dingxin Liu
Olga KovalOlga Koval
Olga Koval
EDElena Dmitrienko
Elena Dmitrienko
Calcium carbonate (CaCO3) micro- and nanoparticles are biocompatible, biodegradable and pH-responsive carriers, but as free suspensions, they aggregate in biological fluids and migrate from the site of administration. A hydrogel matrix prevents both by separating the particles and retaining them locally. The carbonate filler provides the hydrogel with an acid-responsive release profile and mechanical reinforcement, while the released calcium ions confer intrinsic biological activity. This review first relates the synthesis conditions and polymorphic composition of CaCO3 (calcite, aragonite, vaterite and the amorphous phase) to particle stability, dissolution rate and bioactivity. It then considers three roles of the carbonate component in composites: a drug carrier, a source of Ca2+ for ionotropic cross-linking of polymer matrices, and a therapeutically active agent. Integration routes are compared, from mixing of pre-formed particles to internal gelation, in which the dissolving particles release the ions that form the matrix. Release of the active substance proceeds in two consecutive stages: its liberation from the dissolving particle and its diffusion through the polymer network. The rate-limiting stage depends on the acidity of the medium. Bone tissue regeneration and wound healing are the most extensively studied applications, whereas oncology, hemostatic materials and oral delivery remain less explored. Stabilization of metastable polymorphs, reproducible synthesis and long-term safety data are identified as key requirements for clinical translation.